Literature DB >> 24341934

Chronic stress and Parkinson's disease.

Gonglin Hou1, Rui Tian, Jiang Li, Ti-Fei Yuan.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24341934      PMCID： PMC6493127          DOI： 10.1111/cns.12209

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN： 1755-5930            Impact factor:   5.243


× No keyword cloud information.
  10 in total

1.  Stress exacerbates experimental Parkinson's disease.

Authors:  A M Hemmerle; J W Dickerson; J P Herman; K B Seroogy
Journal:  Mol Psychiatry       Date:  2013-09-03       Impact factor: 15.992

Review 2.  Depression in Parkinson's disease -- a review.

Authors:  A Lieberman
Journal:  Acta Neurol Scand       Date:  2006-01       Impact factor: 3.209

Review 3.  Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons.

Authors:  P V Piazza; M L Le Moal
Journal:  Annu Rev Pharmacol Toxicol       Date:  1996       Impact factor: 13.820

4.  Higher incidence of depression preceding the onset of Parkinson's disease: a register study.

Authors:  Albert F G Leentjens; Marjan Van den Akker; Job F M Metsemakers; Richel Lousberg; Frans R J Verhey
Journal:  Mov Disord       Date:  2003-04       Impact factor: 10.338

5.  Tricyclic antidepressants delay the need for dopaminergic therapy in early Parkinson's disease.

Authors:  Katrina L Paumier; Andrew D Siderowf; Peggy Auinger; David Oakes; Lalitha Madhavan; Alberto J Espay; Fredy J Revilla; Timothy J Collier
Journal:  Mov Disord       Date:  2012-05-03       Impact factor: 10.338

6.  Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism.

Authors:  Francisco Ros-Bernal; Stéphane Hunot; Maria Trinidad Herrero; Sebastien Parnadeau; Jean-Christophe Corvol; Lixia Lu; Daniel Alvarez-Fischer; María Angeles Carrillo-de Sauvage; Françoise Saurini; Christiane Coussieu; Kiyoka Kinugawa; Annick Prigent; Günter Höglinger; Michel Hamon; François Tronche; Etienne C Hirsch; Sheela Vyas
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-05       Impact factor: 11.205

7.  Depressive illness in Parkinson's disease--indication of a more advanced and widespread neurodegenerative process?

Authors:  S E Pålhagen; M Carlsson; E Curman; J Wålinder; A-K Granérus
Journal:  Acta Neurol Scand       Date:  2008-02-13       Impact factor: 3.209

8.  Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice.

Authors:  K S Rommelfanger; G L Edwards; K G Freeman; L C Liles; G W Miller; D Weinshenker
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-16       Impact factor: 11.205

9.  Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system.

Authors:  Philippe Remy; Miroslava Doder; Andrew Lees; Nora Turjanski; David Brooks
Journal:  Brain       Date:  2005-02-16       Impact factor: 13.501

10.  Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons.

Authors:  Dipesh Chaudhury; Jessica J Walsh; Allyson K Friedman; Barbara Juarez; Stacy M Ku; Ja Wook Koo; Deveroux Ferguson; Hsing-Chen Tsai; Lisa Pomeranz; Daniel J Christoffel; Alexander R Nectow; Mats Ekstrand; Ana Domingos; Michelle S Mazei-Robison; Ezekiell Mouzon; Mary Kay Lobo; Rachael L Neve; Jeffrey M Friedman; Scott J Russo; Karl Deisseroth; Eric J Nestler; Ming-Hu Han
Journal:  Nature       Date:  2012-12-12       Impact factor: 49.962
  10 in total
  4 in total

1.  Increases in compulsivity, inflammation, and neural injury in HIV transgenic rats with escalated methamphetamine self-administration under extended-access conditions.

Authors:  Giordano de Guglielmo; Yu Fu; Jihuan Chen; Estefania Larrosa; Ivy Hoang; Tomoya Kawamura; Irene Lorrai; Barry Zorman; Joseph Bryant; Olivier George; Pavel Sumazin; Celine Lefebvre; Vez Repunte-Canonigo; Pietro Paolo Sanna
Journal:  Brain Res       Date:  2019-10-09       Impact factor: 3.252

Review 2.  Microglia Gone Rogue: Impacts on Psychiatric Disorders across the Lifespan.

Authors:  Tuan Leng Tay; Catherine Béchade; Ivana D'Andrea; Marie-Kim St-Pierre; Mathilde S Henry; Anne Roumier; Marie-Eve Tremblay
Journal:  Front Mol Neurosci       Date:  2018-01-04       Impact factor: 5.639

Review 3.  Targeting psychologic stress signaling pathways in Alzheimer's disease.

Authors:  Hunter S Futch; Cara L Croft; Van Q Truong; Eric G Krause; Todd E Golde
Journal:  Mol Neurodegener       Date:  2017-06-21       Impact factor: 14.195

4.  Escalated (Dependent) Oxycodone Self-Administration Is Associated with Cognitive Impairment and Transcriptional Evidence of Neurodegeneration in Human Immunodeficiency Virus (HIV) Transgenic Rats.

Authors:  Yu Fu; Irene Lorrai; Barry Zorman; Daniele Mercatelli; Chase Shankula; Jorge Marquez Gaytan; Celine Lefebvre; Giordano de Guglielmo; Hyunjae Ryan Kim; Pavel Sumazin; Federico M Giorgi; Vez Repunte-Canonigo; Pietro Paolo Sanna
Journal:  Viruses       Date:  2022-03-24       Impact factor: 5.818
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.